TAK
Showing 1 - 25 of 915
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Healthy Volunteers Trial in Shanghai (TAK-279, Placebo)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- Placebo
-
Shanghai, ChinaHuashan Hospital Fudan University
Oct 27, 2023
Primary Immunodeficiency Diseases (PID) Trial (TAK-881)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- (no location specified)
Oct 4, 2023
Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- +3 more
-
Tempe, ArizonaCelerion - Tempe, AZ Site
Aug 9, 2023
Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- HYQVIA
- (no location specified)
Feb 23, 2023
Healthy Volunteers Trial in Glendale (TAK-951 Placebo, TAK-951)
Completed
- Healthy Volunteers
- TAK-951 Placebo
- TAK-951
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group
Oct 11, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
No longer available
- Thrombotic Thrombocytopenic Purpura (TTP)
- (no location specified)
Mar 3, 2023
Hepatic Impairment, Healthy Volunteers Trial in Miami, Orlando, San Antonio (TAK-279)
Not yet recruiting
- Hepatic Impairment
- Healthy Volunteers
-
Miami, Florida
- +3 more
Jul 28, 2023
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- TAK-755
- (no location specified)
Feb 9, 2023
Progressive Familial Intrahepatic Cholestasis (PFIC) Trial (TAK-625)
Not yet recruiting
- Progressive Familial Intrahepatic Cholestasis (PFIC)
- (no location specified)
Sep 14, 2022
TAK-660 in Surgical Procedures for People With Hemophilia A.
Active, not recruiting
- Hemophilia A
- PEGylated Recombinant Factor VIII
-
Tokyo, JapanTakeda Selected Site
Dec 13, 2022
Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)
Not yet recruiting
- Myelodysplastic Syndrome
- +4 more
- UAE Inhibitor TAK-243
- (no location specified)
Oct 20, 2022
Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)
Terminated
- Soft-tissue Sarcoma
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 19, 2022
Healthy Volunteers Trial in Tempe, Las Vegas, Austin (TAK-105, TAK-105 Placebo)
Active, not recruiting
- Healthy Volunteers
- TAK-105
- TAK-105 Placebo
-
Tempe, Arizona
- +2 more
Jul 13, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-771)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- (no location specified)
Aug 22, 2022
Healthy Volunteers Trial in Lincoln (TAK-906 Oral Capsule, [14C]-TAK-906 Intravenous Infusion, [14C]-TAK-906 Oral Solution)
Completed
- Healthy Volunteers
- TAK-906 Oral Capsule
- +2 more
-
Lincoln, NebraskaCelerion
Dec 15, 2021